Stock Analysis·← Pickers

WHWK

Whitehawk Therapeutics Inc

Whitehawk Therapeutics Inc (WHWK) is currently in a range/mixed trend, above the 200-day MA but below the 50-day MA. RSI is at 41.9, with 2/3 trend checks passing.

Price
$3.85
2026-07-16
Trend score
2/3
Range / Mixed
RSI (14)
41.9
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

WHWK with MA50 and MA200

5.104.223.352.481.6007/3110/2401/2204/1707/15
WHWK2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$4.25-9.47% vs price
MA200
$3.21+20.04% vs price
RSI (14)
41.9Neutral zone
MACD Signal
BearishMomentum below signal
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for WHWK

Whitehawk Therapeutics Inc (WHWK) looks more range-bound than strongly trending, but there are still a few supportive signs on the chart. The latest available price is $3.85, and 2 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 9.5% and above the 200-day moving average by 20.0%.

Momentum and stretch context

WHWK currently has an RSI reading of 41.9, which leans a little softer than neutral. That does not automatically make the chart bearish, but it does suggest momentum is not especially strong right now.

What traders may watch next

This page is designed to help you quickly understand what the WHWK chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About Whitehawk Therapeutics Inc

Whitehawk Therapeutics Inc. is a biopharmaceutical enterprise currently undergoing clinical trials. This company specializes in crafting highly targeted treatment options for cancers that are identified by distinct genetic profiles.

Sector
Healthcare
Industry
Biotechnology
CEO
David J. Lennon
Employees
29
Market cap
$190.4M
Beta
0.77
52-week range
$1.57 – $5.50
Dividend
No
Exchange
NASDAQ
Country
US
IPO date
1 Aug 2017
ISIN
US00032Q1040
CUSIP
00032Q104
Company profile data from Financial Modeling Prep. WHWK listed on NASDAQ.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about WHWK

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.